Sergio Arruda
Researcher FIOCRUZ, Brazil Tel: +55 71 3176 2232 Email: sergio.arruda@fiocruz.br
VALIDATE Role: Network Investigator
Keywords: Tuberculosis, BCG, leprosy, leishmaniasis
Biography: Mce1a Lipids as Biomarkers for tuberculosis and improvement of BCG vaccine, pathology and pathogenesis of Human cutaneous leishmaniasis.
Related Websites:
Publications: BCG vaccination following latent TB treatment: Possible implications for different settings. Goscé L, Bitencourt J, Gupta RK, Arruda S, Rodrigues LC, Abubakar I. Int J Infect Dis. 2019 ELISA-based assay of immunoglobulin G antibodies against mammalian cell entry 1A (Mce1A) protein: a novel diagnostic approach for leprosy. Lima FR, Takenami I, Cavalcanti MA, Riley LW, Arruda S. Mem Inst Oswaldo Cruz. 2017, 112(12):844-849 Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis. Saldanha MG, Queiroz A, Machado PRL, de Carvalho LP, Scott P, de Carvalho Filho EM, Arruda S. Am J Trop Med Hyg. 2017 Immunoglobulin G response to mammalian cell entry 1A (Mce1A) protein as biomarker of active tuberculosis. Takenami I, de Oliveira CC, Lima FR, Soares J, Machado A Jr, Riley LW, Arruda S. Tuberculosis (Edinb). 2016;100:82-88. |
